Colin Hill co-founded GNS Healthcare in 2000 and serves as Chairman & CEO. He serves on the board of directors of mobile health company – Biotelemetry Inc. (NASDAQ: BEAT), Massachusetts Digital Health Council, biopharmaceutical company AesRx (acquired by Baxter in 2014), and Transforming Medicine: The Elizabeth Kauffman Institute, a non-profit foundation (501c3) dedicated to the advancement of personalized medicine.
In 2004, Colin was named to MIT Technology Review’s TR100 list of the top 100 innovators in the world under the age of 35. He has appeared in numerous publications and television programs, including The Wall Street Journal, CNBC Morning Call & SquawkBox, Nature, Boston Globe, Politico, Forbes, Wired, and The Economist.
He earned a Master’s degree in physics from Cornell University.